Cargando…
Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level o...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337259/ https://www.ncbi.nlm.nih.gov/pubmed/30609687 http://dx.doi.org/10.3390/molecules24010143 |
_version_ | 1783388211845791744 |
---|---|
author | Borges, Rosivaldo S. Palheta, Ivanete C. Ota, Sirlene S. B. Morais, Roberto B. Barros, Valéria A. Ramos, Ryan S. Silva, Rai C. Costa, Josivan da S. Silva, Carlos H. T. P. Campos, Joaquín M. Santos, Cleydson B. R. |
author_facet | Borges, Rosivaldo S. Palheta, Ivanete C. Ota, Sirlene S. B. Morais, Roberto B. Barros, Valéria A. Ramos, Ryan S. Silva, Rai C. Costa, Josivan da S. Silva, Carlos H. T. P. Campos, Joaquín M. Santos, Cleydson B. R. |
author_sort | Borges, Rosivaldo S. |
collection | PubMed |
description | A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level of theory, together with the 6-31+G(d,p) basis sets. Molecular orbital and ionization potential were associated to electron donation capacity. The spin densities contribution showed a preferential hydroxylation at the para-positions of phenyl ring when compared to other positions. In addition, on electron abstractions the aromatic hydroxylation has more impact than alkyl hydroxylation. Docking studies indicate that six structures 1, 7, 8 and 13–15 have potential for inhibiting human as well as murine COX-2, due to regions showing similar intermolecular interactions to the observed for the control compounds (indomethacin and refecoxib). Toxicity can be related to aromatic hydroxylation. In accordance to our calculations, the derivatives here proposed are potentially more active as well safer than phenylbutazone and only structures 8 and 13–15 were the most promising. Such results can explain the biological properties of phenylbutazone and support the design of potentially safer candidates. |
format | Online Article Text |
id | pubmed-6337259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63372592019-01-25 Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism Borges, Rosivaldo S. Palheta, Ivanete C. Ota, Sirlene S. B. Morais, Roberto B. Barros, Valéria A. Ramos, Ryan S. Silva, Rai C. Costa, Josivan da S. Silva, Carlos H. T. P. Campos, Joaquín M. Santos, Cleydson B. R. Molecules Article A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level of theory, together with the 6-31+G(d,p) basis sets. Molecular orbital and ionization potential were associated to electron donation capacity. The spin densities contribution showed a preferential hydroxylation at the para-positions of phenyl ring when compared to other positions. In addition, on electron abstractions the aromatic hydroxylation has more impact than alkyl hydroxylation. Docking studies indicate that six structures 1, 7, 8 and 13–15 have potential for inhibiting human as well as murine COX-2, due to regions showing similar intermolecular interactions to the observed for the control compounds (indomethacin and refecoxib). Toxicity can be related to aromatic hydroxylation. In accordance to our calculations, the derivatives here proposed are potentially more active as well safer than phenylbutazone and only structures 8 and 13–15 were the most promising. Such results can explain the biological properties of phenylbutazone and support the design of potentially safer candidates. MDPI 2019-01-01 /pmc/articles/PMC6337259/ /pubmed/30609687 http://dx.doi.org/10.3390/molecules24010143 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Borges, Rosivaldo S. Palheta, Ivanete C. Ota, Sirlene S. B. Morais, Roberto B. Barros, Valéria A. Ramos, Ryan S. Silva, Rai C. Costa, Josivan da S. Silva, Carlos H. T. P. Campos, Joaquín M. Santos, Cleydson B. R. Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism |
title | Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism |
title_full | Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism |
title_fullStr | Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism |
title_full_unstemmed | Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism |
title_short | Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism |
title_sort | toward of safer phenylbutazone derivatives by exploration of toxicity mechanism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337259/ https://www.ncbi.nlm.nih.gov/pubmed/30609687 http://dx.doi.org/10.3390/molecules24010143 |
work_keys_str_mv | AT borgesrosivaldos towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT palhetaivanetec towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT otasirlenesb towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT moraisrobertob towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT barrosvaleriaa towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT ramosryans towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT silvaraic towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT costajosivandas towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT silvacarloshtp towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT camposjoaquinm towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism AT santoscleydsonbr towardofsaferphenylbutazonederivativesbyexplorationoftoxicitymechanism |